Recursion Pharmaceuticals, Inc. (RXRX)
3.64
-0.02
(-0.55%)
USD |
NASDAQ |
Oct 21, 16:00
3.50
-0.14
(-3.85%)
After-Hours: 04:11
Recursion Pharmaceuticals Net Income (Annual) : -644.76M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -644.76M |
| December 31, 2024 | -463.66M |
| December 31, 2023 | -328.07M |
| December 31, 2022 | -239.48M |
| Date | Value |
|---|---|
| December 31, 2021 | -186.48M |
| December 31, 2020 | -87.01M |
| December 31, 2019 | -61.88M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Absci Corp. | -115.18M |
| Twist Bioscience Corp. | -77.67M |
| Editas Medicine, Inc. | -160.06M |
| Amgen, Inc. | 7.711B |
| Halozyme Therapeutics, Inc. | 316.89M |